Revolutionizing Respiratory Care with AI-Powered Wearable Tech
Aevice Health, a Singapore-based startup, is making waves in the healthcare industry with its innovative AI-powered wearable device, AeviceMD. This 'smart stethoscope' is designed to detect early signs of respiratory attacks, offering a lifeline to those suffering from chronic respiratory conditions.
By Emily Wong
How AeviceMD Works
Chronic respiratory diseases can severely limit a patient's ability to lead a normal life, often making it difficult to even step outside. AeviceMD aims to alleviate these challenges by providing a remote monitoring solution that can detect the early signs of an asthma attack.
The device, which is FDA-approved, is a small, coin-sized disc that is attached to the patient's chest. It continuously monitors vital signs such as heart rate, respiratory rate, lung sounds, and wheezing. The data is then transmitted to healthcare providers, enabling timely interventions and reducing the need for frequent hospital visits.
Benefits for Patients and Healthcare Providers
AeviceMD offers significant benefits for both patients and healthcare providers. For patients, the device reduces the need for frequent hospital visits, allowing them to manage their condition from the comfort of their homes. It also helps in predicting attacks before they become severe, thus improving the overall quality of life.
For healthcare providers, AeviceMD offers a comprehensive platform for remote patient monitoring. The data collected by the device can be stored and reviewed later, allowing for more accurate clinical decisions. This can lead to quicker interventions, potentially preventing severe attacks and reducing the burden on emergency services.
Aevice Health's Journey and Future Plans
Aevice Health was born out of Singapore's prestigious Nanyang Technological University (NTU). The company was founded by Adrian Ang, who has been the CEO since 2018. Ang's personal experience with childhood asthma inspired him to create a solution that could help others manage their condition more effectively.
Recently, Aevice Health secured $7 million in a seed-plus funding round led by Coronet Ventures. The funds will be used to further develop AeviceMD and expand its reach, particularly in Japan, where the company has already established strategic partnerships with local firms.
With the growing prevalence of respiratory diseases worldwide, AeviceMD is poised to become a game-changer in the field of respiratory care, offering a much-needed solution for both patients and healthcare providers.
